Hanmi Science Co Ltd
KRX:008930

Watchlist Manager
Hanmi Science Co Ltd Logo
Hanmi Science Co Ltd
KRX:008930
Watchlist
Price: 32 550 KRW -1.06% Market Closed
Market Cap: 2.2T KRW
Have any thoughts about
Hanmi Science Co Ltd?
Write Note

Hanmi Science Co Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hanmi Science Co Ltd
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Hanmi Science Co Ltd
KRX:008930
Cash from Investing Activities
-â‚©14.8B
CAGR 3-Years
-101%
CAGR 5-Years
14%
CAGR 10-Years
12%
Yuhan Corp
KRX:000100
Cash from Investing Activities
-â‚©153.8B
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
-2%
SK Biopharmaceuticals Co Ltd
KRX:326030
Cash from Investing Activities
â‚©225.3B
CAGR 3-Years
N/A
CAGR 5-Years
42%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Cash from Investing Activities
-â‚©281.9B
CAGR 3-Years
-215%
CAGR 5-Years
-9%
CAGR 10-Years
-12%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Cash from Investing Activities
â‚©10.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-6%
C
Celltrion Pharm Inc
KOSDAQ:068760
Cash from Investing Activities
-â‚©7.8B
CAGR 3-Years
13%
CAGR 5-Years
21%
CAGR 10-Years
14%
No Stocks Found

Hanmi Science Co Ltd
Glance View

Market Cap
2.2T KRW
Industry
Pharmaceuticals

Hanmi Science Co., Ltd. engages in the management of its subsidiaries. The company is headquartered in Hwaseong, Gyeonggi-Do. Through subsidiaries in Japan, Europe and Korea, the Company operates in three segments. The Pharmaceutical Products Wholesale segment mainly engages in the distribution of pharmaceutical products. The Holding Business segment mainly engages in the business of controlling subsidiaries. The Other segment mainly engage in the production and sales of pharmaceuticals, and the supply of quasi-drugs and health functional foods, beverages and functional cosmetics.

Intrinsic Value
26 594.15 KRW
Overvaluation 18%
Intrinsic Value
Price

See Also

What is Hanmi Science Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-14.8B KRW

Based on the financial report for Sep 30, 2024, Hanmi Science Co Ltd's Cash from Investing Activities amounts to -14.8B KRW.

What is Hanmi Science Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
12%

Over the last year, the Cash from Investing Activities growth was -226%. The average annual Cash from Investing Activities growth rates for Hanmi Science Co Ltd have been -101% over the past three years , 14% over the past five years , and 12% over the past ten years .

Back to Top